Kodiak Sciences Inc. (KOD) stock soared 6.06% in intraday trading on Friday.
The sharp increase appears driven by bullish analyst actions, as multiple firms raised their price targets for the biopharmaceutical company. H.C. Wainwright increased its target to $58 from $38, while Jefferies raised its target to $56 from $39.
These substantial upward revisions signal improved analyst confidence and likely prompted investor optimism and buying during the trading session.